Welcome to the e-CCO Library Archive!

Filter:
P366. Skin pathology associated with anti-tumournecrosis factor (anti-TNF) therapy – a single UK IBD centre experience
Authors:

T. Shepherd1, E. Cronin1, K. Greveson1, O. Epstein1, G. Erian1, F. Jaboli1, E. Despott1, M. Hamilton1, C. Murray1, 1Royal Free Hospital, Gastroenterology, London, United Kingdom

P366

Withdrawing or continuing maintenance treatment with thiopurines in patients with Crohn's Disease in sustained clinical remission: a lifetime risk-benefit analysis

Authors:

J. Kirchgesner*1, 2, F. Carrat2, 3, J. Cosnes1, M. Schwarzinger4, L. Beaugerie1, For the BERENICE Study Group1

1Hopital Saint Antoine, Department of Gastroenterology, Paris, France, 2INSERM, University Paris 06 , UMR S 1136 , Paris, France, 3Hopital Saint Antoine, Department of Public Health, Paris, France, 4THEN, Translational Health Economics Network, Paris, France

P367.

Rate of and response to dose escalation in paediatric patients with Crohn's disease from IMAgINE 1

Authors:

M. Dubinsky1, J. Rosh2, W.A. Faubion3, J. Kierkus4, F. Ruemmele5, J. Hyams6, S. Eichner7, Y. Li7, A. Lazar8, R.B. Thakkar7, 1Cedars-Sinai Medical Center, Pediatric Inflammatory Bowel Disease Program, Los Angeles, United States, 2Goryeb Children's Hospital/Atlantic Health, Pediatric Gastroenterology, Morristown, United States, 3Mayo Clinic, Gastroenterology, Rochester, United States, 4The Children's Memorial Health Institute, Gastroenterology, Hepatology and Feeding Disorders, Warsaw, Poland, 5Universite Sorbonne Paris-Cite, Hospital Necker-Enfants Malades, APHP, Paris, France, 6Connecticut Children's Medical Center, Division of Digestive Diseases, Hartford, United States, 7AbbVie Inc, GPRD, North Chicago, United States, 8AbbVie Deutschland GmbH & Co, KG, GPRD, Ludwigshafen, Germany

P367. Analysis of 33 Crohn's disease risk loci in Chinese inflammatory bowel disease patients shows role of autophagy in CD individuals
P367. Compliance to the scheduled treatment with infliximab. Experience in a tertiary care hospital
P367. Thiopurine metabolites measurement more effective in guiding IBD management when done during disease flare as supposed to during remission
Authors:

T. Tandiari1, G. Eslick2, R. Leong1, 1Concord Repatriation General Hospital, Gastroenterology and Liver Services, Sydney, Australia, 2The Whiteley-Martin Research Centre, Gastroenterology, Sydney, Australia

P367

Dietary fiber intake in children with Inflammatory Bowel Disease

Authors:

A. Pituch-Zdanowska, A. Banaszkiewicz, P. Albrecht*

Medical University of Warsaw, Dept. of Pediatric Gastroenterology and Nutrition, Warsaw, Poland

P368.

Rare skin disorders in IBD patients treated with anti-TNFs

Authors:

V. Prieto1,2, A. Fernandez1, A. Velasco1, C. Piñero1, J. Umaña1, Y. Jamanca1, A. Mora1, A. Rodriguez1, 1Hospital Clínico de Salamanca, Gastroenterology, Salamanca, Spain, 2Hospital Clínico de Salamanca, Medicine, Salamanca, Spain

P368. Are inherited thrombotic risk factors associated with fibrostenosis in Crohn's disease?
P368. Routine practice of iron infusion therapy in IBD
P368. Serological response to the 23-valent pneumococcal polysaccharide vaccine in patients with Crohn's disease: preliminary results of a prospective, multicentre study
Authors:

C.K. Lee1, H.-S. Kim2, H.-J. Kim1, W. Moon3, K.M. Lee4, J.-S. Koo5, G.S. Seo6, S.J. Park7, B.D. Ye8, C.H. Choi9, S.-A. Jung10, Y.S. Kim11, J.P. Im12, E.S. Kim13, S.N. Hong14, 1Kyung Hee University, South Korea, 2Yonsei University Wonju College of Medicine, South Korea, 3Kosin University, South Korea, 4The Catholic University of Korea, South Korea, 5Korea University, South Korea, 6Wonkwang University, South Korea, 7Yonsei University, South Korea, 8University of Ulsan, South Korea, 9Chung-Ang University, South Korea, 10Ewha Womans University, South Korea, 11Inje University, South Korea, 12Seoul National University, South Korea, 13Keimyung University, South Korea, 14Konkuk University, South Korea

P368

Ustekinumab in super-refractory Crohn´s disease patients

Authors:

C. Herrera*, V. Robles, C. Jimenez, E. Navarro, F. Casellas, N. Borruel

Unitat Atenció Crohn-Colitis. Hospital Universitari Vall d'Hebron, Digestive System Research Unit, Barcelona, Spain

P369.

Rapid infusion, high dose ferric carboxymaltose in the treatment of iron deficiency in paediatric inflammatory bowel disease – a single centre experience

Authors:

N. Carman, R. Muir, P. Lewindon, Royal Children's Hospital, Gastroenterology Department, Brisbane, Australia

P369. Dysbiosis in inflammatory bowel disease: A link with antimicrobial peptides secretion?
P369. Improvement in CT scan assessment correlates with clinical response to therapy in Crohn's disease patients
P369. Side effects in inflammatory bowel disease patients treated with biological therapy: our experience
Authors:

M.J. Carrillo1, R. Beltrán1, B. Maldonado1, C. Duarte1, L. Castro1, F. Argüelles1, A. Benitez1, A. Caunedo1, F. Pellicer1, J.M. Herrerias1, 1Hospital Virgen Macarena, Sevilla, Spain

P369

Diffusion-Weighted magnetic resonance enterocolonography before treatment predicts remission after anti-TNF therapy in Crohn's disease

Authors:

A. Buisson*1, 2, C. Hordonneau3, M. Goutte1, 2, J. Scanzi1, F. Goutorbe1, T. Klotz3, L. Boyer3, B. Pereira4, G. Bommelaer1, 2

1University Hospital Estaing, Gastroenterology Department, Clermont-Ferrand, France, 2UMR 1071 Inserm/Université d'Auvergne; USC-INRA 2018, Microbes, Intestine, Inflammation and Susceptibility of the host, Clermont-Ferrand, France, 3University Hospital Estaing, Radiology Department, Clermont-Ferrand, France, 4GM – Clermont-Ferrand University and Medical Center, , Biostatistics Unit , Clermont-Ferrand, France

P370.

Prospective withdrawal trial of azathioprine (AZA) in ulcerative colitis (UC)

Authors:

C. Pratico', N. Capozzi, F. Rizzello, A. Calafiore, R. Brugnera, G. Straforini, G. Spuri Fornarini, M. Campieri, C. Calabrese, P. Gionchetti, University of Bologna, Internal Medicine, Bologna, Italy

P370. Formation of antiphospholipid antibodies (APLA) is associated to the presence of anti-Saccharomyces cerevisiae antibodies (ASCA) in inflammatory bowel disease
P370. Pregnancy and newborn outcome of mothers with inflammatory bowel disease exposed to anti-TNFα therapy during pregnancy: Three‑centre study